1-1 of 1
from the Food and Drug Administration’s Center for Drug Evaluation and Research, Division of Cardiovascular and Renal Products, Division of Pediatric and Maternal Health, and Office of Pediatric Therapeutics
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
News

Adult drug effective for pediatric patients with dilated cardiomyopathy and heart failure

from the Food and Drug Administration’s Center for Drug Evaluation and Research, Division of Cardiovascular and Renal Products, Division of Pediatric and Maternal Health, and Office of Pediatric Therapeutics
Published: June 2019
Abstract
The FDA has approved ivabradine (Corlanor) for treatment of heart failure in children with dilated cardiomyopathy.
View News